drug development

Medidata acquires Shyft for $195M, establishes unified trial, commercialization data platform
By Dave Muoio | 11:18 am | June 12, 2018
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced today that it has acquired Shyft Analytics, maker of a cloud data analytics platform specifically designed for the pharma and biotech industries.
BenevolentAI gets $115M to harness AI for new drug discovery
By Jonah Comstock | 02:03 pm | April 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States.